These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7802728)

  • 1. Familial lipoprotein disorders and premature coronary artery disease.
    Schaefer EJ; Genest JJ; Ordovas JM; Salem DN; Wilson PW
    Atherosclerosis; 1994 Aug; 108 Suppl():S41-54. PubMed ID: 7802728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid abnormalities in Greek patients with coronary artery disease.
    Elisaf MS; Siamopoulos KC; Tselegarides TJ; Bairaktari ETh ; Goudevenos JA; Tselepis AD; Tsolas OE; Sideris DA
    Int J Cardiol; 1997 Apr; 59(2):177-84. PubMed ID: 9158172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial lipoprotein disorders in patients with premature coronary artery disease.
    Genest JJ; Martin-Munley SS; McNamara JR; Ordovas JM; Jenner J; Myers RH; Silberman SR; Wilson PW; Salem DN; Schaefer EJ
    Circulation; 1992 Jun; 85(6):2025-33. PubMed ID: 1534286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial lipoprotein disorders and premature coronary artery disease.
    Schaefer EJ
    Med Clin North Am; 1994 Jan; 78(1):21-39. PubMed ID: 8283932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah.
    Williams RR; Hopkins PN; Hunt SC; Wu LL; Hasstedt SJ; Lalouel JM; Ash KO; Stults BM; Kuida H
    Arch Intern Med; 1990 Mar; 150(3):582-8. PubMed ID: 2310276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
    Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
    J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease.
    Genest J; McNamara JR; Ordovas JM; Jenner JL; Silberman SR; Anderson KM; Wilson PW; Salem DN; Schaefer EJ
    J Am Coll Cardiol; 1992 Mar; 19(4):792-802. PubMed ID: 1531990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypoalphalipoproteinemia in premature coronary artery disease.
    Genest J; Bard JM; Fruchart JC; Ordovas JM; Schaefer EJ
    Arterioscler Thromb; 1993 Dec; 13(12):1728-37. PubMed ID: 8241092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.
    Stein EA; Sniderman A; Laskarzewski P
    Am J Cardiol; 2005 Nov; 96(9A):36K-43K; discussion 34K-35K. PubMed ID: 16291013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond low-density lipoprotein cholesterol. A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess.
    Rosenson RS
    Arch Intern Med; 1996 Jun; 156(12):1278-84. PubMed ID: 8651835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic aspects of lipid abnormalities.
    Criqui MH; Golomb BA
    Am J Med; 1998 Jul; 105(1A):48S-57S. PubMed ID: 9707268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing dyslipidemia in Turkey: suggested guidelines for a population characterized by low levels of high density lipoprotein cholesterol.
    Bersot TP; Palaoğlu KE; Mahley RW
    Anadolu Kardiyol Derg; 2002 Dec; 2(4):315-22. PubMed ID: 12460830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.
    Ordovas JM; Schaefer EJ; Salem D; Ward RH; Glueck CJ; Vergani C; Wilson PW; Karathanasis SK
    N Engl J Med; 1986 Mar; 314(11):671-7. PubMed ID: 3081805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.